Clinical Trial Update: Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

View source ↗

Summary

Post-marketing surveillance trial update for Alhemo® in patients with Haemophilia A or Haemophilia B with inhibitors; the study is currently enrolling by invita…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• ALHEMO (Concizumab)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Haemophilia A, Haemophilia B | Status: ENROLLING_BY_INVITATION